Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:216-224
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mathier, M. A.
Right arrow Articles by Semigran, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathier, M. A.
Right arrow Articles by Semigran, M. J.

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy

Michael A. Mathier, MDa, Geoffrey A. Rose, MDa, Michael A. Fifer, MD, FACCa, Michael I. Miyamoto, MDa, Robert E. Dinsmore, MDa, Hugo H. Castaño, MDa, G. William Dec, MD, FACCa, Igor F. Palacios, MD, FACCa and Marc J. Semigran, MDa

a Cardiac Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA



View larger version (13K):

[in a new window]
 
Figure 1 Epicardial CSA response to graded intracoronary doses of acetylcholine (Ach) and a 5% dextrose control infusion (C1) in patients with acute-onset DCM and in control patients (CTRL). Acetylcholine infusion produced no change in CSA in control patients but a significant epicardial constriction in patients with DCM. *p < 0.05, {dagger}p < 0.01 versus C1. {ddagger}p < 0.05 versus control patients.

 


View larger version (13K):

[in a new window]
 
Figure 2 CBF response to graded intracoronary doses of acetylcholine (Ach) and a 5% dextrose control infusion (C1) in patients with acute-onset DCM and in control patients (CTRL). Acetylcholine infusion produced an increase in CBF in control patients but no change in patients with DCM. *p < 0.01 versus C1. {dagger}p < 0.05 versus patients with DCM.

 


View larger version (12K):

[in a new window]
 
Figure 3 CSA and CBF responses to intracoronary infusion of 10–4 mol/liter adenosine and a 0.9% NaCl control infusion (C2) in patients with acute-onset DCM and control patients (CTRL). Adenosine infusion produced significant increases in CSA and CBF in both groups. The magnitude of the responses did not differ between DCM and control patients.

 


View larger version (16K):

[in a new window]
 
Figure 4 Plots of the relation between coronary responses to acetylcholine infusion and a 5% dextrose control infusion (C1) and subsequent improvement in LVEF in patients with acute-onset dilated cardiomyopathy. Left, Association between the epicardial CSA response during infusion of 10–6 mol/liter acetylcholine and improvement in LVEF on follow-up. Right, Association between the CBF response during infusion of 10–6 mol/liter acetylcholine and improvement in LVEF at follow-up.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement